Alere Files Appeal With CMS Judge Over Medicare Billing Decision
Health-care diagnostics company Alere is taking steps to get Medicare billing privileges reinstated for its Arriva Medical LLC diabetes unit, challenging the actions of the Centers for Medicare and Medicaid Services. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 28, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Trump's Health Pick Traded Medical Stocks While in House
Donald Trump ’s pick for HHS secretary, Rep. Tom Price, traded more than $300,000 in shares of health-related companies in the past four years while advocating legislation that could affect those companies’ stocks. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 23, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Cintas Posts Higher Earnings From Continuing Operations
Cintas Corp. reported a 6.9% increase in earnings from continuing operations for its fiscal second quarter, posting its 13th consecutive quarter of gross margin improvement. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 22, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Teva Settles Foreign Corruption Probe for $519 Million
Teva Pharmaceutical Industries agreed to pay $519 million to settle U.S. charges that it violated U.S. foreign-bribery law in its operations in Ukraine, Mexico and Russia. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 22, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
De Blasio Launches Health-Law Push
New York City Mayor Bill de Blasio wants to enroll 50,000 people in health insurance under the Affordable Care Act by the end of next year, a move officials said would save the city ’s cash-strapped hospital system $40 million a year. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 21, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
GlaxoSmithKline's New Drug Challenges HIV Treatment Orthodoxy
GlaxoSmithKline ’s ViiV Healthcare announced positive phase-three trial results for its new HIV drug in a dual-drug regimen, supporting the company’s audacious bet that it can shift the treatment orthodoxy away from three-drug combinations. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 20, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Canada Fails to Reach Deal on Health Funding With Local Governments
The Canadian government failed to reach a deal on health care funding during a meeting with regional health and finance ministers on Monday, as rising costs continue to squeeze the country ’s single-payer system. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 20, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Female Doctors' Hospital Patients May Have An Edge
Hospital patients treated by female physicians had a small survival edge over those with male doctors, a new study of more than 58,000 physicians found. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 20, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Biogen Names New CEO
Biogen Inc. said Monday it has named veteran biopharmaceutical executive Michel Vounatsos, head of the company ’s commercial organization, its next chief executive. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 19, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Hospitals Alter Routines to Control Drug Spending
U.S. hospitals are taking aggressive steps to cut pharmaceutical spending. They include minimizing inventories and repackaging costly intravenous medicines into individual doses. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 19, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
States Sue Generic-Drug Firms Over Price-Fixing Allegations
Twenty state attorneys general sued a group of generic drug companies Thursday, accusing them of conspiring to fix prices on an antibiotic and a diabetes medication. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 16, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
DNA Vaccines: Next Defense Against Zika, Other Invaders
Experimental DNA vaccines could shield against infectious-disease outbreaks that now spread around the world with alarming speed. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 16, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Gilead Sciences Ordered to Pay $2.5 Billion in Damages to Merck & Co.
A federal jury in Delaware on Thursday ordered Gilead Sciences Inc. to pay $2.5 billion in damages to Merck& Co. for infringing its patents in developing hepatitis C drugs. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 15, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Big Hospital Operator Retreats From Health-Insurance Foray
Catholic Health Initiatives, one of the biggest U.S. hospital operators, is retreating from an ambitious plan to run its own insurance firm, underscoring the risks for health-care providers seeking to compete with health insurers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 15, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Sanofi, Actelion Seek to Iron Out Differences in Deal Talks
French drug company Sanofi ’s attempts to acquire Swiss biotech firm Actelion could hit the same roadblock as a similar attempt by J&J, now abandoned: price. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 15, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
